|
 |
The HemoCue Albumin 201 system can be used for the quantitative determination of low levels of albumin in urine for the purpose of screening, diagnosis, monitoring and supporting clinical evidence in the treatment of microalbuminuria. Existing point-of-care tests (POCT) are either semi-quantitative (dipsticks) or based on expensive bench-top instrumentation. By providing the accuracy of a central lab right at the point-of care, the HemoCue Albumin 201 system helps healthcare professionals act with complete confidence. The new HemoCue Albumin 201 system consists of a small, specially designed analyzer and individually packaged microcuvettes containing freeze-dried reagent. The test is performed at the point-of-care using a microcuvette filled by capillary action. All that is needed to obtain a quantitative result are: fill the microcuvette, place it in the analyzer and read the result. The HemoCue Albumin 201 system is based on an immunoturbidimetric reaction using anti-human albumin antibodies. The antigen-antibody complex creates turbidity, which is measured photometrically at 610 nm. The albumin concentration is proportional to the turbidity and the result is shown on the display in mg/L. |
|
|
|
|
|
 |
|
|
|
| Excellent precision and accuracy Quantitative results in about 90 seconds Factory-calibrated instrument Measurement range of 7-150 mg/L |
|
|
|
|
|
